Close

Ratings by WBB Securities (Steve Brozak)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/10/2022 Paratek Pharmaceuticals PRTK Upgrade Strong Buy
(Speculative Buy)
3.97
(2.09)
-47.36% Details
2/2/2022 ContraFect Corp. CFRX Upgrade Buy
(Hold)
2.93
(0.06)
-97.95% Details
6/18/2021 Omeros Corp. OMER Maintain Strong Buy
(N/A)
 
 
  Details
5/28/2021 Redhill Biopharma RDHL Downgrade Buy
(Strong Buy)
7.14
(0.23)
-96.78% Details
4/23/2021 Paratek Pharmaceuticals PRTK Upgrade Buy
(Speculative Buy)
7.87
(2.09)
-73.44% Details
3/31/2021 ContraFect Corp. CFRX New Coverage Speculative Buy
(N/A)
4.48
(0.06)
-98.66% Details
1/8/2020 Paratek Pharmaceuticals PRTK New Coverage Speculative Buy
(N/A)
4.15
(2.09)
-49.64% Details
7/12/2019 Redhill Biopharma RDHL Upgrade Strong Buy
(Buy)
6.59
(0.23)
-96.51% Details
3/29/2019 Marker Therapeutics MRKR Upgrade Strong Buy
(Buy)
6.71
(2.30)
-65.72% Details
3/12/2019 Redhill Biopharma RDHL Upgrade Buy
(Speculative Buy)
8.27
(6.59)
-20.31% Details